As expected in the pristane model, treated mice did not develop kidney disease and shown by renal histology scores (S1 Fig); moreover both RIPK3-/- and B6 mice of both sexes developed similar levels of anti-nuclear antibodies (Fig 2A). The gene discussed is RIPK3; the disease is kidney disorder.